Trial Profile
Virological and Clinical Anti-HBV Efficacy of Tenofovir in Antiretroviral naïve Patients With HIV/HBV Co-infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary) ; Efavirenz; Lamivudine; Lamivudine/zidovudine; Zidovudine
- Indications Hepatitis B; HIV-1 infections
- Focus Therapeutic Use
- Acronyms TICO
- 01 Apr 2009 Results published in Hepatology.
- 10 Apr 2008 Additional lead trial centre and investigator identified as reported by ClinicalTrials.gov.
- 16 Nov 2005 New trial record.